Diabetic Foot Files

This episode explains "failure to thrive" in adults with diabetes — a multifactorial clinical syndrome where poor nutrition, inflammation, and chronic disease prevent wound healing.It reviews warning signs, key lab markers (albumin, prealbumin, CRP, A1c), and a practical multidisciplinary approach — nutrition, glycemic control, infection management, vascular care, and mobilization — to reverse the cycle and improve outcomes.

In this episode Dr G examines how the healthcare system—not just clinical decisions—affects diabetic wound outcomes, highlighting how insurance rules, financial barriers, transportation and approval delays can lead to infection, osteomyelitis and even amputations. She shares real patient stories and examples of denied imaging and approvals that changed outcomes.
Her takeaways: prioritize early specialist (especially vascular) care and prevention, speak up about financial limits, use community resources, and push for system changes to expand preventive coverage and reduce approval delays so money doesn’t decide who heals.

This episode makes one simple point: do not drive on a diabetic foot ulcer or while wearing a cam boot, post‑op shoe, or with an uncovered ulcer. It explains the biomechanics of pedal use, how repetitive pressure, shear, and impaired sensation worsen wounds, and how driving can delay healing or lead to deep infection and amputation.The host outlines clinical consequences, practical alternatives (medical transport, rideshare, caregivers, vehicle modifications, telemedicine), and actions clinicians can take (education, documentation, consent). The episode stresses honest communication and realistic plans to protect limbs while preserving independence.

Join Diabetic Foot Files as Dr. Asha Zimmerman MD , a transplant surgeon who left practice to develop the primary intelligence app which is geared towards informing patients about their health and wellness. Dr Zimmerman discusses Primary Intelligence, an AI-driven app designed to inform patients before doctor visits, improve screening and prevention, and enhance patient–provider communication.
Learn how AI can support early identification of complications, empower patient advocacy, and potentially expand access to evidence-based care while keeping clinicians in the loop.
You can learn more about the Primary Intelligence App at 
https://www.primaryintelligence.ai
 

Dr. Jay Patel joins Diabetic Foot Files to explain peripheral arterial disease (PAD) in diabetes, from screening and imaging to cutting-edge endovascular treatments that restore blood flow and enable wound healing. He discusses why diabetics often develop below-the-knee disease, the role of neuropathy, and practical first-line care including smoking cessation, supervised exercise, and statins.
The episode emphasizes early vascular referral for non-healing wounds or rest pain, outlines outpatient endovascular options and recovery, and shares real-world limb salvage success—underscoring that timely diagnosis and revascularization can prevent amputation and improve quality of life.
More with Dr. Jay Patel at 
https://texaseva.com/about-us/dr-jay-patel/

This episode explores how diabetic foot infections, psychiatric medications, and certain antibiotics can interact to cause delirium, psychosis, serotonin syndrome, and other neuropsychiatric effects. It reviews high‑risk antibiotic classes (fluoroquinolones, cefepime, metronidazole, linezolid), common drug‑drug risks, and clinical red flags.Learn practical management strategies: review all medications, check renal and metabolic status, involve psychiatry and infectious disease, choose safer antibiotic alternatives when needed, monitor vital signs and QTc, and prioritize communication and trust to protect both mind and limb.

In this episode of Diabetic Foot Files we break down transitional offloading — the critical, fragile phase after a diabetic foot ulcer closes when reintroducing pressure too quickly can reopen wounds.
We cover the physiology of healed tissue, the biomechanics of pressure, a phased protocol (strict offloading, protected weight bearing, custom orthotics, then monitored full activity), case examples, and modern tools like pressure mapping and smart insoles.
Key takeaways: gradual pressure reintroduction, proper footwear and orthotics, daily foot inspections, and ongoing multidisciplinary follow-up to reduce high recurrence risk.

This episode explores diabetic autonomic neuropathy — the widespread nerve damage from chronic high blood sugar that affects the heart, gastrointestinal tract, bladder, sweat glands and more. It explains how this condition can cause silent heart attacks, resting tachycardia, orthostatic symptoms, gastroparesis, bladder and sexual dysfunction, and why diabetic foot ulcers may be a visible sign of deeper systemic disease.We cover the main mechanisms (polyol pathway, AGEs, oxidative stress, microvascular ischemia), how clinicians diagnose it (heart rate variability, tilt-table, troponin, imaging), and practical prevention and management steps: tight glucose control, vascular care, blood pressure and cholesterol management, exercise, and multidisciplinary follow-up.

Dr. G explains quorum sensing — the chemical "language" bacteria use to coordinate biofilm formation, virulence, and antibiotic resistance in diabetic foot ulcers.He covers how biofilms form, why diabetic wounds favor them, the role of debridement, and emerging treatments (quorum sensing inhibitors, enzymes, bacteriophages, nanoparticles) to disrupt bacterial communication and improve healing.

In this episode Dr. G explores chlorophyll’s surprising history and medical potential — from its chemical similarity to hemoglobin and wartime use as a wound antiseptic to the development of chlorophyllin.We cover the science behind its antimicrobial effects (photodynamic action, toxin binding, anti-inflammatory signaling), its role in odor control and granulation, and why researchers are revisiting it amid rising antibiotic resistance.The episode connects these findings to diabetic wound challenges and ongoing research into chlorophyll derivatives as adjuncts in modern wound care.